165 related articles for article (PubMed ID: 6124402)
41. Diphenylhydantoin elimination kinetics in overdosed children.
Garrettson LK; Jusko WJ
Clin Pharmacol Ther; 1975 Apr; 17(4):481-91. PubMed ID: 1122689
[TBL] [Abstract][Full Text] [Related]
42. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism.
Maguire JH
Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891
[TBL] [Abstract][Full Text] [Related]
43. Metabolism of diphenylhydantoin (phenytoin) during pregnancy.
Landon MJ; Kirkley M
Br J Obstet Gynaecol; 1979 Feb; 86(2):125-32. PubMed ID: 427051
[TBL] [Abstract][Full Text] [Related]
44. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation.
Cuttle L; Munns AJ; Hogg NA; Scott JR; Hooper WD; Dickinson RG; Gillam EM
Drug Metab Dispos; 2000 Aug; 28(8):945-50. PubMed ID: 10901705
[TBL] [Abstract][Full Text] [Related]
45. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
Hoppel C; Garle M; Rane A; Sjöqvist F
Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648
[TBL] [Abstract][Full Text] [Related]
46. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
47. Metabolism of [14C]-5-chloro-1,3-benzodioxol-4-amine in male Wistar-derived rats following intraperitoneal administration.
Athersuch TJ; Duckett CJ; Castro-Perez J; Rodgers C; Nicholson JK; Wilson ID
Xenobiotica; 2007 Jan; 37(1):44-58. PubMed ID: 17178633
[TBL] [Abstract][Full Text] [Related]
48. Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
Borgå O; Hoppel C; Odar-Cederlöf I; Garle M
Clin Pharmacol Ther; 1979 Sep; 26(3):306-14. PubMed ID: 466924
[TBL] [Abstract][Full Text] [Related]
49. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous determination of plasma phenytoin and its primary hydroxylated metabolites in carbon tetrachloride-intoxicated rats by high-performance liquid chromatography.
Tanaka E; Sakamoto N; Inubushi M; Misawa S
J Chromatogr B Biomed Appl; 1995 Nov; 673(1):147-51. PubMed ID: 8925069
[TBL] [Abstract][Full Text] [Related]
51. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
52. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
53. Excretion of phenytoin into semen of rabbits and man. Comparison with plasma levels.
Swanson BN; Leger RM; Gordon WP; Lynn RK; Gerber N
Drug Metab Dispos; 1978; 6(1):70-4. PubMed ID: 23276
[TBL] [Abstract][Full Text] [Related]
54. Effect of dose on the metabolism of 1,1,2,2-tetrabromoethane in F344/N rats after gavage administration.
Kennedy CH; Cohen KB; Bechtold WE; Chang IY; Eidson AF; Dahl AR; Henderson RF
Toxicol Appl Pharmacol; 1993 Mar; 119(1):23-33. PubMed ID: 8470121
[TBL] [Abstract][Full Text] [Related]
55. 5,5-Bis(3-hydroxyphenyl)hydantoin, a minor metabolite of diphenylhydantoin (dilantin) in the rat and human.
Thompson RM; Beghin J; Fife WK; Gerber N
Drug Metab Dispos; 1976; 4(4):349-56. PubMed ID: 8289
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice.
Koller-Lucae SK; Suter MJ; Rentsch KM; Schott H; Schwendener RA
Drug Metab Dispos; 1999 Mar; 27(3):342-50. PubMed ID: 10064564
[TBL] [Abstract][Full Text] [Related]
57. Urinary excretion of phenytoin metabolites, 5-(4'-hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases.
Yamanaka H; Nakajima M; Hara Y; Katoh M; Tachibana O; Yamashita J; Yokoi T
Drug Metab Pharmacokinet; 2005 Apr; 20(2):135-43. PubMed ID: 15855726
[TBL] [Abstract][Full Text] [Related]
58. Determination of 5-(p-hydroxyphenyl)-5-phenylhydantoin and studies relating to the disposition of phenytoin in man.
Witkin KM; Bius DL; Teague BL; Wiese LS; Boyles LW; Dudley KH
Ther Drug Monit; 1979; 1(1):11-34. PubMed ID: 553326
[TBL] [Abstract][Full Text] [Related]
59. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
60. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
